Loading...
Equillium, Inc.
EQ•NASDAQ
HealthcareBiotechnology
$0.38
$0.02(6.39%)
Equillium, Inc. (EQ) Financial Performance & Statements
Review Equillium, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
13.89%
↑ 13.89%
Operating Income Growth
43.06%
↑ 43.06%
Net Income Growth
39.51%
↑ 39.51%
Operating Cash Flow Growth
12.66%
↑ 12.66%
Operating Margin
-47.18%
↓ 47.18%
Gross Margin
99.77%
↑ 99.77%
Net Profit Margin
-46.00%
↓ 46.001%
ROE
-74.35%
↓ 74.35%
ROIC
-133.75%
↓ 133.75%
Equillium, Inc. (EQ) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Equillium, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $4.39M | $12.16M | $13.85M |
| Cost of Revenue | $0.00 | $35000.00 | $0.00 | $35000.00 |
| Gross Profit | $0.00 | $4.36M | $12.16M | $13.82M |
| Gross Profit Ratio | $0.00 | $0.99 | $1.00 | $1.00 |
| R&D Expenses | $5.92M | $7.32M | $9.56M | $10.81M |
| SG&A Expenses | $2.95M | $1.77M | $3.28M | $3.15M |
| Operating Expenses | $8.87M | $9.09M | $12.84M | $13.95M |
| Total Costs & Expenses | $0.00 | $9.09M | $12.84M | $13.95M |
| Interest Income | $173000.00 | $239000.00 | $331000.00 | $371000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $35000.00 | $35000.00 | $35000.00 |
| EBITDA | -$8.87M | -$5.40M | $28000.00 | $503000.00 |
| EBITDA Ratio | -$1.23 | $0.002 | $0.04 | |
| Operating Income | -$8.87M | -$4.70M | -$679000.00 | -$100000.00 |
| Operating Income Ratio | -$1.07 | -$0.06 | -$0.007 | |
| Other Income/Expenses (Net) | $216000.00 | -$735000.00 | $672000.00 | $568000.00 |
| Income Before Tax | -$8.65M | -$5.43M | -$7000.00 | $468000.00 |
| Income Before Tax Ratio | -$1.24 | -$0.001 | $0.03 | |
| Income Tax Expense | $0.00 | $361000.00 | $0.00 | $0.00 |
| Net Income | -$8.65M | -$5.79M | -$7000.00 | $468000.00 |
| Net Income Ratio | -$1.32 | -$0.001 | $0.03 | |
| EPS | -$0.24 | -$0.16 | -$0.00 | $0.01 |
| Diluted EPS | -$0.24 | -$0.16 | -$0.00 | $0.01 |
| Weighted Avg Shares Outstanding | $35.59M | $35.36M | $35.42M | $35.29M |
| Weighted Avg Shares Outstanding (Diluted) | $35.59M | $35.36M | $35.42M | $36.59M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan